Substance P and neurokinin A regulate by different mechanisms dopamine release from dendrites and nerve terminals of the nigrostriatal dopaminergic neurons

Neuroscience

Volumn 25, Issue 3, 1988, Pages 889-898

  Baruch, P ^a   Artaud, F ^a   Godeheu, G ^a   Barbeito, L ^a   Glowinski, J ^a   Cheramy A ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROKININ A; NEUROKININ B; RADIOISOTOPE; SUBSTANCE P; TYROSINE;

ANIMAL EXPERIMENT; CAT; CORPUS STRIATUM; DENDRITE; DOPAMINE RELEASE; FEMALE; MALE; NERVE ENDING; NONHUMAN; SUBSTANTIA NIGRA;

ANIMAL; CATS; CORPUS STRIATUM; DENDRITES; DOPAMINE; FEMALE; GLUTAMATES; GLUTAMIC ACID; MALE; NERVE ENDINGS; NEUROKININ A; NEUROPEPTIDES; RILUZOLE; SUBSTANCE P; SUBSTANTIA NIGRA; SUPPORT, NON-U.S. GOV'T; THIAZOLES;

EID: 0023915249     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-4522(88)90042-5     Document Type: Article

References (78)

1. Regional distribution of neuropeptide K and other tachykinins (neurokinin A, neurokinin B and substance P) in rat central nervous system
2. GABAergic and glycinergic mechanisms within the substantia nigra: pharmacological specificity of dopamine independent contralateral turning behavior and interactions with other neurotransmitters
3. 125I-Bolton Hunter derivatives of eledoisin and substance P in the rat brain
4. 2-Amino-6-trifluoromethoxybenzothiazole, a possible antagonist of the excitatory aminoacid neurotransmission. II. Biochemical properties
5. 3H-Neurokinin A labels a specific tachykinin binding site in the rat duodenal smooth muscle
6. 125I-Bolton Hunter eledoisin label identical tachykinin binding sites in the rat brain
7. Location of substance P-like immunoreactivity in neurons and nerve terminals in the neostriatum of the rat: a correlate light and electron microscopic study
8. Tachykinin multiplicity in rat central nervous system as studied using antisera raised against substance P and neurokinin A
9. On the origin of substance P and glutamic acid decarboxylase (GAD) in the substantia nigra
10. Reduction in basal ganglia and substantia nigra substance P levels in Huntington's disease
11. 3H-dopamine in the ipsilateral caudate nucleus of the cat
12. Effects of the immunoneutralization of substance P in the rat substantia nigra on the release of dopamine from dendrites and terminals of dopaminergic neurons
13. Effects of unilateral electrical stimulation of various thalamic nuclei on the release of dopamine from dendrites and nerve terminals of neurons of the two nigro-striatal dopaminergic pathways
14. In vivo presynaptic control of dopamine release in the cat caudate nucleus. II. Facilitatory or inhibitory influence ofl-glutamate
15. Striato-nigral dynorphin and substance P pathways in the rat.I. Biochemical and immunohistochemical studies
16. Actions of substance P and opiates in the rat substantia nigra
17. Substance P in the substantia nigra
18. Substance K and substance P differentially modulate mesolimbic and mesocortical systems
19. Regional distribution of substance P-like immunoreactivity in the lower brainstem of the rat
20. Regional distribution of methionine-enkephalin and substance P-like immunoreactivity in normal human brain and in Huntington's disease
21. Human brain substance P: distribution in controls and Huntington's chorea
22. Topographical distribution of substance P in cat substantia nigra
23. The role of dopamine released from distal and proximal dendrites of nigrostriatal dopaminergic neurons in the control of GABA transmission in the thalamic nucleus ventralis medialis in the cat
24. Presynaptic effects ofl-glutamic acid on the release of dopamine in rat striatal slices
25. Enhancement of glutamate release in the rat striatum following electrical stimulation of the nigrothalamic pathway
26. The regional distribution of kassinin-like immunoreactivity in central and peripheral tissues of the cat
27. Distribution of substance P and enkephalin-like immunoreactivity in the substantia nigra of rat, cat and monkey
28. Substance K excites dopaminergic and non-dopaminergic neurons in rat substantia nigra
29. Behavioral and biochemical effects of substance P injected into the substantia nigra of the rat
30. Effects of substance P injected into the substantia nigra
31. Topographic projections of substance P and GABA pathways in the striato-and pallido-nigral system: a biochemical and immunohistochemical study
32. Substance K and substance P in the ventral tegmental area
33. Evidence for a decrease in substance P content of substantia nigra in Huntington's chorea
34. On the origin of substance P-containing fibres in the entopeduncular nucleus and the substantia nigra of the rat
35. Regional distribution of substance P, neurokinin alpha and neurokinin beta in rat central nervous system
36. Nigrostriatal dopamine neurons receive substance P-ergic inputs in the substantia nigra: application to the immunoelectron microscopic mirror technique to fluorescent double-staining for transmitter-specific projections
37. Substance P infusion into substantia nigra of the rat: behavioural analysis and involvement of striatal dopamine
38. Structure and gene organization of bovine neuromedin K precursor
39. Three rat preprotachykinin mRNAs encode the neuropeptides substance P and neurokinin A
40. The localization and characterization of substance P and substance K in striato-nigral neurons
41. Calcium-dependent potassium-stimulated release of neurokinin A and neurokinin B from rat brain regions in vitro
42. Regional distribution and in vivo release of tachykinin-like immunoreactivities in rat brain: evidence for regional differences in relative proportion of tachykinins
43. Neurokinin A and substance P in striato-nigral neurons in rat brain
44. Distribution of substance P-like immunoreactivity in the central nervous system of the rat.I. Cell bodies and nerve terminals
45. Distribution of substance P-like immunoreactivity in the central nervous system of the rat. II. Light microscopic localization in relation to catecholamine-containing neurons
46. Role of the dendritic release of dopamine in the reciprocal control of the two nigro-striatal dopaminergic pathways
47. Regional distribution of kassinin-like immunoreactivity in rat central and peripheral tissues and the effect of capsaicin
48. 3H-substance P receptor binding in the rat brain after kainic acid lesion of the corpus striatum
49. Immunocytochemical studies of substance P and leucine-enkephalin in Huntington's disease
50. In vivo release of substance P in the cat substantia nigra
51. Effects of the unilateral nigral modulation of substance P transmission on the activity of the two nigro-striatal dopaminergic pathways
52. Regional distribution of neuromedin K and neuromedin L in rat brain and spinal cord
53. 2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of the excitatory amino acid neurotransmission.I. Anticonvulsant properties
54. Nucleotide sequences of cloned cDNAs for two types of bovine brain substance P precursor
55. Tissue-specificic generation of two preprotachykinin mRNAs from one gene by alternative RNA splicing
56. Release of dopamine evoked by electrical stimulation of the motor and visual areas of the cerebral cortex in both caudate nuclei and in the substantia nigra in the cat
57. Rotatory behavior in rats by intranigral application of substance P and an eledoisin fragment
58. The glutamate decarboxylase-, leucine enkephalin-, methionine enkephalin- and substance P-immunoreactive neurons in the neostriatum of the rat and cat: evidence for partial population overlap
59. 3H-dopamine from rat striatal slices: a tetrodotoxin sensitive process
60. Differential sensitivity of presumed dopaminergic and non-dopaminergic neurones in rat substantia nigra to electrophoretically applied substance P
61. Multiple tachykinin receptors
62. Multiple tachykinin receptors in guinea pig brain. High densities of substance K (neurokinin A) binding sites in the substantia nigra
63. Autoradiographic distribution of substance P receptors in rat central nervous system
64. The co-occurrence of substance P-like immunoreactivity and dynorphin-like immunoreactivity in striatopallidal and striatonigral projection neurons in birds and reptiles
65. 3H-5-hydroxytryptamine from rat substantia nigra in vitro
66. Neuronal localization of substance P receptors in rat neostriatum
67. 3H-dopamine release from rat striatum: an in vitro model for glutamate actions
68. In vivo presynaptic control of dopamine release in the cat caudate nucleus.I. Opposite changes in neuronal activity and release evoked from thalamic motor nuclei
69. In vivo presynaptic control of dopamine release in the cat caudate nucleus. III. Further evidence for the implication of corticostriatal glutamatergic neurons
70. Visualization of rat brain receptors for the neuropeptide substance P
71. A comparison of the anatomical distribution of substance P and substance P receptors in the rat central nervous system
72. Demonstration and distribution of kassinin-like material (substance K) in the rat central nervous system
73. Synaptosomal uptake and release of dopamine in substantia nigra: effects of gamma-aminobutyric acid and substance P
74. Synaptic connections of substance P-immunoreactive nerve terminals in the substantia nigra of the rat
75. Distribution of substance K (neurokinin A) in the brain and peripheral tissues of rats
76. Increased dopamine metabolism in rat striatum after infusion of substance P into the substantia nigra
77. The action of substance P on mesencephalic reticular and substantia nigral neurones of the rat
78. Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain